Locus Coeruleus Noradrenergic Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The locus coeruleus (LC) is the primary source of norepinephrine (NE) in the central nervous system and represents one of the earliest sites of tau pathology in Alzheimer's disease (AD). These neurons project widely throughout the brain and play crucial roles in attention, arousal, and memory consolidation. Their degeneration contributes significantly to the cognitive decline observed in AD. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000459 | noradrenergic cell |
| Database | ID | Name | Confidence | [2]
|----------|----|------|------------| [3]
| Cell Ontology | CL:0000459 | noradrenergic cell | Exact | [4]
| Cell Ontology | CL:0008025 | noradrenergic neuron | Exact | [5]
The locus coeruleus is located in the dorsal pontine tegmentum and contains approximately 15,000-20,000 noradrenergic neurons in the adult human brain. Key features include: [6]
Efferent Projections:
Afferent Inputs:
LC neurons regulate brain state through:
Norepinephrine acts through:
The LC exhibits remarkable vulnerability in AD:
LC dysfunction contributes to:
Norepinephrine Reuptake Inhibitors:
α2-Adrenergic Agonists:
The study of Locus Coeruleus Noradrenergic Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Zarow C, et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. 2003. ↩︎
Marien MR, et al. The locus coeruleus-noradrenergic system: Functional organization and potential clinical significance. 2020. ↩︎
Matchett BJ, et al. The mechanistic role of the locus coeruleus in neurodegeneration: A gateway to cognitive decline. 2021. ↩︎
Totterdell S, et al. Aging and the locus coeruleus-noradrenergic system. 2022. ↩︎
Gannon M, et al. Noradrenergic dysfunction in Alzheimer's disease. 2015. ↩︎
Rommelfanger KS, Weinshenker D. Norepinephrine: The redheaded stepchild of Parkinson's disease. 2007. ↩︎